5236102022-07-012022-09-305236102022-09-305236102022-03-315236102022-04-012022-09-305236102022-07-012022-09-30in-bse-fin:OtherExpenses1Member5236102022-04-012022-09-30in-bse-fin:OtherExpenses1Memberiso4217:INRxbrli:pureiso4217:INRxbrli:shares523610ITINOTLISTEDINE248A01017ITI LimitedEquity2022-04-012023-03-312022-11-112022-11-02INRLakhsHalf yearlySingle segmentBy virtue of being engaged in Defence Production, the company is exempt from the necessity of segment reporting, according to the MCA's Notification dated February 23, 2018.2022-11-1111:30:002022-11-1114:30:00trueCash Flow IndirectNot applicable2022-07-012022-09-30UnauditedStandalone197553210010456090020800930004406975006762040005574924005104961005013231001187281002785273003083468500-10033755000-10033755000000-10033755000000-1003375500-37151800-104052730000949577350010-1.07-1.0700-1.07-1.070001. The above financial results for the period ended 30.09.2022 were reviewed by the Audit Committee on 11.11.2022 and upon its recommendations, were approved by the Board of Directors at their meeting held on 11.11.2022 <BR> 2. These financial results have been prepared in accordance with the Indian Accounting Standards (Ind-AS) as prescribed under Section 133 of the Companies Act, 2013 read with Rule 3 of the Companies (Indian Accounting Standards) Rules, 2015, as amended. <BR> 3. A Limited Review of the above Unaudited Financial Results has been carried out by the Statutory Auditors of the Company pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosures Requirements) Regulations,2015. <BR> 4. By virtue of being engaged in Defence Production, the company is exempt from the necessity of segment reporting, according to the MCA's Notification dated February 23, 2018. <BR> 5. The Company is currently under a revival plan after it was referred to the BIFR and declared a sick company. The Cabinet Committee on Economic Affairs (CCEA) approved the revival plan based on the recommendations of the Board for Reconstruction of Public Sector Enterprise (BRPSE) which involves financial assistance of Rs. 4,15,679 lakhs, of which the Company as of date has received Rs.2,19,835 lakhs. <BR> 6. The Other Current Financial Asset include unbilled Revenue of Rs.203704.85 Lakhs . The Revenue which has been recognised over the last few years based on the work performed , the billing of which would happen upon fulfilling the terms of the contract. <BR> 7. During the period under Audit, the DoT had not agreed with the proposal of the Company to provide VRS to employees on Medical ground out of VRS Grant in Aid . Hence VRS expenses on Medical ground which was paid during FY 2019-20 and adjusted against the Grant in Aid is now recognised as expense. <BR> 8. The previous period /year comparatives have been restated (based on audited annual financial statements) and regrouped wherever necessary to conform to the current period’s presentation. <BR> 9. During the first half of the financial year 2022-23, the Company has allotted 83,21,279 equity shares of Rs.10/- each at a price of Rs.86/- and 77,33,204 equity shares of Rs.10/- each at a price of Rs.103.45. <BR> 10. EPS calculation: <BR> Quarter ended Half Year Ended <BR> As at 30.09.2022 As at 30.09.2022 <BR> Profit After Tax (10,034) (19,980) <BR> Less: <BR> Preference Dividend - - <BR> Dividend tax - - <BR> Profit available to equity shareholders (10,034) (19,980) <BR> No. of Shares at beginning of the period 941844148 933522869 <BR> No. of Shares issued during the period. 7733204 16054483 <BR> No. of Shares at the end of the period. 949577352 949577352 <BR> Weighted average no of shares during the period 939427733 939427733 <BR> Earning per equity share (for continuing operation): <BR> Basic & Diluted( in Rs ) (1.07) (2.13) <BR> <BR> 11. The above results are available at www.itiltd.in and website of stock exchanges at www.bseindia.com and nseindia.com. <BR> 2022-04-012022-09-30UnauditedStandalone363831080032435600039626668002603161100843905300-27526160010126019009573519002383497005805988005960707100-19980403000-19980403000000-19980403000000-1998040300-74303700-207234400000949577350010-2.13-2.1300-2.13-2.130.0074-0.00560.0126Other Expenses278527300Other Expenses580598800266361632001540983800683289600000004055000263628400042000156100026419420000520003150243060024164673000256377806004996720021744389008006252000203778327005624627140001613618400602763571000091778787700949577350015091719600245874931002458749310024000000002400000000448683900450106000742914600404170450015480150000178801213001731406130050674332600109045657001570691800631495901006719129460091778787700957351900-4825130004340829000-274054000-25574640000-4750800000-32010047000-9746841000238349700030802800-13241100000011323700000-16288300025100000-743037000-332400300-233044060000000-233044060000000000162883000286424800000000000000000000113237000734781300622563200008000000000000017595512000000957351900001602199300-1056781000-10567810015565420049976100003715180074303700